JudithESobermanMDMHA, FACC, FHRS, CCDS
Cardiology • Memphis, TNCardiac Electrophysiology, Heart Failure & Transplantation, Non-Invasive Cardiology, Preventive Cardiology
Professor of Medicine, UT Health Science Center - Memphis Chief Medical Officer, Paradox Pharmaceuticals, Inc
Dr. Soberman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1910 Nonconnah Blvd
Ste 120
Memphis, TN 38132Phone+1 901-448-2300Fax+1 901-448-6657
Education & Training
University of MemphisMHA, Healthcare Administration, Honors, 2005 - 2009
Montefiore Medical Center/Albert Einstein College of Medicine (Montefiore)Fellowship, Cardiovascular Disease, 1985 - 1988
Jacobi Medical Center/Albert Einstein College of MedicineResidency, Internal Medicine, 1982 - 1985
University of Pittsburgh School of MedicineClass of 1982
Certifications & Licensure
TN State Medical License 1988 - 2027- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Fellow Heart Rhythm Society, 2009
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- 1 citationsPivarubicin Is More Effective Than Doxorubicin Against Triple-Negative Breast Cancer In Vivo.Leonard Lothstein, Judith Soberman, Deanna Parke, Jatin S. Gandhi, Trevor W. Sweatman
Oncology Research. 2020-12-10 - 20 citationsPartial Meal Replacement Plan and Quality of the Diet at 1 Year: Action for Health in Diabetes (Look AHEAD) TrialHollie A. Raynor, Andrea Anderson, Gary D. Miller, Rebecca Reeves, Linda M. Delahanty
Journal of the Academy of Nutrition and Dietetics. 2015-05-01 - 9 citationsCardioselective beta-blocker treatment of hypertension in patients with asthma: when do benefits outweigh risks?Timothy H. Self, Jessica L. Wallace, Judith E. Soberman
The Journal of Asthma. 2012-10-11
Professional Memberships
- Member
Industry Relationships
- Chief Medical Officer, Paradox Pharmaceuticals, IncParadox is a start up pharmaceutical company that endeavors to develop unique oncologic agents that are non-cardiotoxic.2010 - 2014
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
